161 related articles for article (PubMed ID: 33544438)
1. Somatostatin receptors: an alternative treatment target for advanced Merkel cell carcinoma.
Br J Dermatol; 2021 Feb; 184(2):e32-e52. PubMed ID: 33544438
[TBL] [Abstract][Full Text] [Related]
2. High somatostatin receptor expression and efficacy of somatostatin analogues in patients with metastatic Merkel cell carcinoma.
Akaike T; Qazi J; Anderson A; Behnia FS; Shinohara MM; Akaike G; Hippe DS; Thomas H; Takagishi SR; Lachance K; Park SY; Tarabadkar ES; Iyer JG; Blom A; Parvathaneni U; Vesselle H; Nghiem P; Bhatia S
Br J Dermatol; 2021 Feb; 184(2):319-327. PubMed ID: 32320473
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report.
Guida M; D'Alò A; Mangia A; Di Pinto F; Sonnessa M; Albano A; Sciacovelli A; Asabella AN; Fucci L
Front Oncol; 2020; 10():1073. PubMed ID: 32733801
[No Abstract] [Full Text] [Related]
4. Immunotherapy for Merkel Cell Carcinoma.
Nagase K; Narisawa Y
Curr Treat Options Oncol; 2018 Sep; 19(11):57. PubMed ID: 30238195
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor expression in Merkel cell carcinoma: correlation with clinical data.
Fagerstedt KW; Vesterinen T; Leijon H; Sihto H; Böhling T; Arola J
Acta Oncol; 2023 Sep; 62(9):1001-1007. PubMed ID: 37540574
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin Receptors 2A and 5 Are Expressed in Merkel Cell Carcinoma with No Association with Disease Severity.
Gardair C; Samimi M; Touzé A; Coursaget P; Lorette G; Caille A; Wierzbicka E; Croué A; Avenel-Audran M; Aubin F; Kerdraon R; Estève E; Beneton N; Guyétant S
Neuroendocrinology; 2015; 101(3):223-35. PubMed ID: 25765179
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for Merkel cell carcinoma: a turning point in patient care.
Chan IS; Bhatia S; Kaufman HL; Lipson EJ
J Immunother Cancer; 2018 Mar; 6(1):23. PubMed ID: 29566749
[TBL] [Abstract][Full Text] [Related]
8. Merkel Cell Carcinoma Therapeutic Update.
Cassler NM; Merrill D; Bichakjian CK; Brownell I
Curr Treat Options Oncol; 2016 Jul; 17(7):36. PubMed ID: 27262710
[TBL] [Abstract][Full Text] [Related]
9. Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
Garcia-Carbonero R; Marquez-Rodas I; de la Cruz-Merino L; Martinez-Trufero J; Cabrera MA; Piulats JM; Capdevila J; Grande E; Martin-Algarra S; Berrocal A
Oncologist; 2019 Oct; 24(10):1375-1383. PubMed ID: 30962295
[TBL] [Abstract][Full Text] [Related]
10. [Immune checkpoint inhibition in Merkel cell carcinoma].
Terheyden P; Mohr A; Langan EA
Hautarzt; 2019 Sep; 70(9):684-690. PubMed ID: 31468071
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor positron emission tomography/computed tomography imaging in Merkel cell carcinoma.
Sollini M; Taralli S; Milella M; Erba PA; Rubagotti S; Fraternali A; Roncali M; Moscarella E; Perotti G; Rufini V; Versari A
J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1507-11. PubMed ID: 26446694
[TBL] [Abstract][Full Text] [Related]
12. Targeting the epigenetic addiction of Merkel cell carcinoma.
Mauri F; Blanpain C
EMBO Mol Med; 2020 Nov; 12(11):e13347. PubMed ID: 33063436
[TBL] [Abstract][Full Text] [Related]
13. [Recent update on tumour biology and treatment of Merkel Cell carcinoma].
Steinstraesser L; Kueckelhaus M; Koljonen V
Handchir Mikrochir Plast Chir; 2011 Dec; 43(6):345-9. PubMed ID: 22241518
[TBL] [Abstract][Full Text] [Related]
14. Remission of Merkel cell tumor after somatostatin analog treatment.
Fakiha M; Letertre P; Vuillez JP; Lebeau J
J Cancer Res Ther; 2010; 6(3):382-4. PubMed ID: 21119285
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.
Femia D; Prinzi N; Anichini A; Mortarini R; Nichetti F; Corti F; Torchio M; Peverelli G; Pagani F; Maurichi A; Mattavelli I; Milione M; Bedini N; Corti A; Di Bartolomeo M; de Braud F; Pusceddu S
Target Oncol; 2018 Oct; 13(5):567-582. PubMed ID: 30073632
[TBL] [Abstract][Full Text] [Related]
16. Avelumab: a new standard for treating metastatic Merkel cell carcinoma.
Baker M; Cordes L; Brownell I
Expert Rev Anticancer Ther; 2018 Apr; 18(4):319-326. PubMed ID: 29482384
[TBL] [Abstract][Full Text] [Related]
17. Pembrolizumab and other immune checkpoint inhibitors in locally advanced or metastatic Merkel Cell Carcinoma: safety and efficacy.
Marchand A; Kervarrec T; Bhatia S; Samimi M
Expert Rev Anticancer Ther; 2020 Dec; 20(12):1093-1106. PubMed ID: 33044876
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for Merkel cell carcinoma.
Angeles CV; Sabel MS
J Surg Oncol; 2021 Mar; 123(3):775-781. PubMed ID: 33595894
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.
Guadagni S; Farina AR; Cappabianca LA; Sebastiano M; Maccarone R; Zelli V; Clementi M; Chiominto A; Bruera G; Ricevuto E; Fiorentini G; Sarti D; Mackay AR
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153070
[TBL] [Abstract][Full Text] [Related]
20. Successful targeted radiotherapy with 90Y-DOTATOC in a patient with Merkel cell carcinoma. A Case Report.
Meier G; Waldherr C; Herrmann R; Maecke H; Mueller-Brand J; Pless M
Oncology; 2004; 66(2):160-3. PubMed ID: 15138369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
